IL1B and COVID-19: In the case of COVID-19, SARS-CoV-2 infection triggers a cascade of molecular disturbances, including excessive cytokine release (IL-6, TNF-α, and IL-1β), microglial activation, and oxidative stress, leading to neuroinflammation and neuronal dysfunction.